HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
View All | Scroll Down Scroll Up
Quote:
Login Free Membership
Search:

Corporate Summary  

Company News for February 6, 2012

Share
By: Zacks Equity Research
February 06, 2012 | Comment(s): 0
Recommended this article (6)
EL | IDIX | GILD | GNW | SNE


•    Estee Lauder Companies, Inc.’s (NYSE:EL - Analyst Report) second quarter 2012 quarterly earnings increased 17% year over year to $1.00 per share, but missed the Zacks Consensus Estimate of $1.01 by a penny

•    After concerns arose that Idenix Pharmaceuticals, Inc.’s (Nasdaq:IDIX - Snapshot Report) hepatitis C drug would be unable  to compete with Gilead Sciences, Inc. (Nasdaq:GILD - Analyst Report) drug, shares of Idenix declined by 11.5%

•    Genworth Financial Inc’s (NYSE:GNW - Analyst Report) fourth quarter operating income came in at $0.17 per share, in line with the Zacks Consensus Estimate

•    Sony Corporation (NYSE:SNE - Snapshot Report) reported that it has laid off 100 employees over the past few weeks
 

Read the full analyst report on EL

Read the full analyst report on IDIX

Read the full analyst report on GILD

Read the full analyst report on GNW

Read the full analyst report on SNE

 

Please login to Zacks.com or register to post a comment.
Disclosure / Disclaimer Link


Email
Print
Share
Rate Pos
Rate Neg
Attn. Zacks.com Visitors
7 Best Stocks for the Next 30 Days
Get your free Welcome Gifts today*:
 1.  Special Report with best short-term Zacks recommendations from the list that averages a gain of +26% per year
 2.  Our free e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

More Zacks Links

Market Summary May 26, 2012 19:43 pm ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center

Top Zacks Features

Free Membership
Zacks Rank
Equity Research
Portfolio Tracker
Screening
Premium Screens
Mutual Funds
Options
Zacks Video
Education
RSS Feed
Profit from the Pros

Subscription Services

Product Guide
Method for Trading
Chart Patterns
FTM Trader
Home Run Investor
Income Plus
Insider Trader
Options Trader
Reitmeister Alert
Tactical Trader
Top 10 Stocks
Turnaround Trader
Whisper Trader
Research Wizard
People & Picks
Zacks Premium
Zacks Ultimate
Zacks.com: About Zacks | Education | Advertise | Affiliate | Media | Careers | Contact Us | Services | Help | Disclaimer | Privacy Policy | Sitemap

Copyright 2011 Zacks Investment Research

Zacks Investment Research is one of the most highly regarded firms in the investment industry. The guiding principle behind our work is that there must be a good reason for brokerage firms to spend billions of dollars a year on stock research. Obviously, these investment experts know something special that may be indicative of the future direction of stock prices. From day one, we were determined to unlock that secret knowledge and make it available to our clients to help them improve their investment results.

NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.